Mycoprotein: How Fungi Protein Is Scaling Toward a USD 1.19 Billion Market
Updated: 4 days ago
Executive summary. The plant-based meat boom promised to replace burgers and sausages within a decade. It did not. Sales stalled, prices stayed high and consumers grew wary of long ingredient lists. Mycoprotein, the fungi-based protein grown by fermentation, has had a different path: older than the plant-based wave, simpler on the label and increasingly used not only on its own but blended into meat and other products. Strategic Revenue Insights estimates the global mycoprotein market at USD 480.00 million in 2025, rising to USD 1.19 billion by 2035 at a 9.5 percent compound annual growth rate. Demand for meat alternatives, sustainability pressure, fermentation scale-up and clean label and protein trends are driving it. This article sets out five lessons from the producers, brands and food companies moving first, with takeaways for strategy, product, operations, channels and revenue.
The structure of the market explains where growth will land. Strategic Revenue Insights' Mycoprotein Market research finds that frozen products are the largest form at 48.00 percent of 2025 value while dried mycoprotein is the fastest growing, that Fusarium venenatum is the largest source at 62.00 percent while Neurospora is the fastest growing, that meat alternatives are the largest application at 58.00 percent while dairy alternatives are the fastest growing, and that retail is the largest channel while online is the fastest growing. Europe is the largest region at 38.00 percent of 2025 value, and Asia Pacific is the fastest growing. The research names high production cost and regulatory approval time as restraints, and lists Quorn Foods, Enough, Meati Foods, MycoTechnology, Nature's Fynd, Mycorena, Atlast Food, Emergy, Prime Roots and Libre Foods among the leading companies, with Quorn estimated at a 24.0 percent share.
The category leader's recent results show a business stabilising rather than booming. Quorn's UK operator, Marlow Foods, reported 2025 sales down 1.0 percent but an underlying operating loss halved to GBP 6 million, while its UK market share rose 0.9 points to 31.0 percent, according to accounts reported in April 2026. Its parent Monde Nissin reported first-half 2026 revenue for the business up 2.2 percent at constant currency, driven by snacking and the UK launch of Protein Bites. In July 2026 Quorn launched UltiMeat blends with William White Meats, pairing mycoprotein with meat for foodservice, and in the United States Meati Holdings acquired the Meati assets in October 2025 with a relaunch planned for 2026.
Why the Mycoprotein Market Is Entering a New Phase
Three structural forces are converging.
The plant-based reset has changed the brief. After a period of falling sales in meat alternatives, retailers and brands are pruning ranges and backing products with short labels, good taste and a clear protein story. Mycoprotein's single whole-food ingredient and high protein and fibre content fit that brief better than many highly processed plant-based products.
Blending has opened a larger market. Instead of asking consumers to give up meat, food companies are blending mycoprotein into meat products, ready meals and snacks to cut cost, fat and carbon. SRI's research lists hybrid products blending mycoprotein with meat or plant protein as an opportunity, and Quorn's UltiMeat move shows the strategy in practice.
Fermentation is scaling. SRI's research names fermentation scale-up as a driver. Larger fermentation plants, new strains and continuous processes are lowering cost per kilogram, while new sources such as Neurospora, the fastest growing source in SRI's research, widen the range of textures and uses.
These forces explain SRI's forecast of steady growth to 2035, with value concentrating in hybrids, dairy alternatives and Asia Pacific.
Five Lessons From the Companies Moving First
The producers and brands turning these forces into advantage share a recognisable pattern. We have distilled it into five lessons, each followed by a takeaway for a specific leadership function.
Lesson 1: Sell Protein and Simplicity, Not Meat Replacement
The first wave of alternative protein marketing promised a product that tasted exactly like meat. Many consumers tried it and did not come back. The companies stabilising mycoprotein sales now lead with what the ingredient is: a high-protein, high-fibre, whole-food protein made by fermentation, with a short ingredient list.
That positioning reaches a wider audience than committed vegetarians, including flexitarians, health-focused shoppers and consumers looking for convenient protein. Quorn's growth in snacking and its Protein Bites launch reflect the shift from replacing meat toward meeting everyday protein needs.
The same protein-led repositioning is reshaping other categories, as described in how the GLP-1 consumer is resetting meal replacement, where protein density has become the main purchase driver.
"Consumers stopped buying the promise that a product tastes exactly like meat. They keep buying protein that is simple, tasty and good for them."
Takeaway on strategy. Position mycoprotein on protein, fibre and a short label rather than on imitating meat. Target flexitarian, health and convenience occasions, and expand into snacks and everyday formats.
Lesson 2: Hybrid Products Are the Volume Opportunity
SRI's research lists hybrid products blending mycoprotein with meat or plant protein as an opportunity. Blending lets meat processors and foodservice operators lower cost, fat and carbon per portion without asking diners to change habits, and it creates demand for mycoprotein as an ingredient sold to other food companies.
The companies moving first sell mycoprotein both as a branded product and as a business-to-business ingredient. Ingredient sales smooth demand, use fermentation capacity more fully and reach consumers who would never buy a meat-free product. Quorn's UltiMeat blends with William White Meats are an early example in foodservice.
Takeaway on product. Develop mycoprotein as a business-to-business ingredient for meat, ready meal and snack makers alongside branded products, and co-develop hybrid recipes with processors and foodservice chains.
Lesson 3: Fermentation Cost Decides the Price
SRI's research names high production cost as the largest restraint and the capital intensity of fermentation plants as a challenge. Mycoprotein competes with soy and pea protein, which SRI's research names as a cost challenge, so every reduction in cost per kilogram widens the market.
The companies moving first invest in larger and more continuous fermentation, higher-yield strains, cheaper feedstocks such as food industry side streams, and energy-efficient downstream processing. SRI's research lists precision fermentation capacity partnerships with food brands as an opportunity, which spreads the capital burden and secures offtake.
"In fermentation, scale is the recipe. The producer with the cheapest kilogram of protein will set the pace for the whole category."
Takeaway on operations. Prioritise cost per kilogram through scale, strain yield, low-cost feedstocks and efficient processing. Share capacity investment through partnerships that come with long-term offtake from food brands.
Lesson 4: Foodservice and Dairy Open New Doors
SRI's research lists foodservice menu adoption in quick-service chains as an opportunity and identifies dairy alternatives as the fastest growing application. Foodservice lets consumers try mycoprotein without buying a pack, and chains value consistent supply and functionality more than brand names.
Dairy alternatives are a newer frontier. Fungi-based ingredients can provide creaminess and protein in yoghurts, cheeses and spreads. SRI's research also lists dairy alternatives and whole-cut formats as an opportunity. The companies moving first build application labs and work with chefs and dairy brands to develop products that perform in real kitchens.
The premium plant-protein dynamics are similar to those in how a shrinking orchard is creating a premium plant-protein category, where functionality and clean label support a price premium.
Takeaway on channels. Build foodservice partnerships with quick-service and contract caterers, invest in dairy and whole-cut applications, and support customers with application labs and chef development.
Lesson 5: Europe Leads, Asia Pacific Grows Fastest
SRI's research identifies Europe as the largest region and Asia Pacific as the fastest growing. Europe, and the United Kingdom in particular, has the most mature mycoprotein market, anchored by Quorn. Asia Pacific offers growth from rising protein demand, a cultural familiarity with fermented foods and government interest in food security and alternative proteins.
Regulation shapes entry. SRI's research names regulatory approval time as a restraint, because novel food approvals for new strains can take years. The companies moving first plan approvals early, partner with local food companies and adapt products to local cuisines.
The capabilities that decide who captures this demand are specific:
A protein and simplicity positioning that reaches beyond vegetarians.
Business-to-business ingredient sales for hybrid products.
Low cost per kilogram from scaled fermentation.
Foodservice and dairy application capability.
Early novel food approvals and local partners in Asia Pacific.
Companies evaluating these competitive dynamics in greater detail can use SRI's Mycoprotein Market analysis to assess form, source, application and distribution segments and the positioning of the leading producers.
Takeaway on market development. Defend and grow the European base, file novel food approvals early in Asia Pacific, and enter through local partners and products adapted to regional cuisines.
Where the Opportunity Is Concentrating
Value is moving toward ingredients, hybrids and new applications.
By form, frozen products are the largest segment while dried mycoprotein is the fastest growing, as ingredient and shelf-stable uses expand.
By source, Fusarium venenatum is the largest segment and Neurospora is the fastest growing.
By application, meat alternatives are the largest segment while dairy alternatives are the fastest growing.
By channel, retail is the largest while online is the fastest growing, and by geography Europe is the largest region while Asia Pacific grows fastest.
At the Horizon: What to Watch Over the Next Three Years
Hybrid product launches. The number of meat processors and foodservice chains adopting mycoprotein blends will show whether the ingredient strategy scales.
Fermentation capacity. New plants and capacity partnerships will determine how fast cost per kilogram falls.
Novel food approvals. Approvals for new strains and new markets, especially in Asia Pacific, will set the pace of geographic expansion.
"The next phase of mycoprotein will not be won by the most convincing burger. It will be won by the producer whose protein quietly ends up in thousands of other foods."
The Strategic Revenue Opportunity
For mycoprotein producers, the task is to lower cost and build ingredient sales alongside brands. For meat processors and food companies, the opportunity is in hybrid products that cut cost and carbon. For foodservice operators, the priority is consistent, versatile protein for menus. For investors, the signal is fermentation capacity, ingredient contracts and approvals.
Market intelligence turns these questions into decisions. Segment-level sizing shows where form, source and application demand is concentrating, competitive analysis shows how producers are positioned, and regional analysis shows where protein demand and regulation will pull growth first. This is the path from market signals to strategic insight to revenue impact.
Takeaway on revenue. Treat the mycoprotein market as four revenue pools: branded retail products sold on taste and simplicity, ingredients sold to food manufacturers for hybrids, foodservice supply sold on consistency, and dairy and new formats sold through co-development. Each needs its own pricing model.
The Next Leg: Preparing for the Journey Ahead
The defining shift in mycoprotein is that it is moving from a meat substitute to a protein ingredient. That changes who buys it, how it is priced and where it grows. The companies moving first are not the ones with the most aggressive marketing; they are the ones leading on protein and simplicity, selling ingredients for hybrids, cutting fermentation cost, opening foodservice and dairy and planning for Asia Pacific.
The next three years will decide which producers become the default fungi protein suppliers to the food industry. Decision-makers should invest in fermentation scale, build ingredient partnerships and track hybrid launches, capacity and approvals. Companies evaluating growth opportunities in this market can use Strategic Revenue Insights' Mycoprotein Market report to assess market size, competitive dynamics, regional opportunities and strategic growth priorities.
Sources: Strategic Revenue Insights, Mycoprotein Market report (2026); Marlow Foods 2025 accounts (reported April 2026).
Frequently Asked Questions
How big is the mycoprotein market?
Strategic Revenue Insights estimates the global mycoprotein market at USD 480.00 million in 2025, rising to USD 1.19 billion by 2035 at a 9.5 percent compound annual growth rate. Europe is the largest region at 38.00 percent of 2025 value, while Asia Pacific is the fastest growing.
What is driving growth in mycoprotein?
Demand for meat alternatives, sustainability pressure, the scale-up of fermentation and clean label and protein trends are the main drivers. Hybrid products that blend mycoprotein with meat or plant protein are opening a larger market than meat-free products alone.
Which mycoprotein segments lead the market?
Frozen products are the largest form, Fusarium venenatum is the largest source, meat alternatives are the largest application and retail is the largest channel. Dried mycoprotein, Neurospora, dairy alternatives and online sales are the fastest growing segments, according to Strategic Revenue Insights.
What are the main challenges for mycoprotein producers?
High production cost and the capital needed for fermentation plants are the main challenges, along with cost competition from soy and pea protein, consumer acceptance of fungi and the time it takes to win regulatory approval for new strains.
About the authors: This article was prepared by the Strategic Revenue Insights research team, which combines market intelligence, competitive analysis and strategic advisory for growth-stage, mid-market and enterprise organisations across the food and beverage sector. Sector analyst: Sandeepa Kulkarni, Research Analyst. Our market estimates combine primary research (interviews, surveys and expert panels) with secondary data (industry reports, databases and public disclosures); read more about how Strategic Revenue Insights works. To discuss this market with our analysts, contact our team.
Comments